Immunovant (IMVT) Invested Capital (2019 - 2023)
Immunovant's (IMVT) quarterly Invested Capital came in at $350000.0 in Q1 2023, up 104.68% YoY from $171000.0 in Q1 2022, and up 104.68% on a QoQ basis from $171000.0 in Q1 2022.
Immunovant (IMVT) Invested Capital (2019 - 2023) Analysis & Trends
Immunovant (IMVT) has 4 years of Invested Capital data on file, last reported at $350000.0 in Q1 2023.
- Quarterly Invested Capital rose 104.68% year-over-year to $350000.0 in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $350000.0 (up 104.68% YoY) and the FY2023 annual result came in at $350000.0, up 104.68% from the prior year.
- Invested Capital advanced to $350000.0 in Q1 2023, from $171000.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $5.0 million in Q2 2019 to a low of $58000.0 in Q1 2019.
- A 4-year average of $1.7 million and a median of $350000.0 in 2023 frame the typical range for Invested Capital.
- The widest YoY moves for Invested Capital: up 5400.0% in 2020, down 94.64% in 2020.
- Tracing IMVT's Invested Capital over 4 years: stood at $3.1 million in 2019, then sank by 95.72% to $134000.0 in 2020, then increased by 27.61% to $171000.0 in 2022, then surged by 104.68% to $350000.0 in 2023.
- The last three Invested Capital figures came in at $350000.0 (Q1 2023), $171000.0 (Q1 2022), and $134000.0 (Q3 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Immunovant | 8.63 Bn | 7.83 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 350,000.00 |
| Mar 31, 2022 | 171,000.00 |
| Sep 30, 2020 | 134,000.00 |
| Jun 30, 2020 | 336,000.00 |
| Mar 31, 2020 | 3.19 Mn |
| Dec 31, 2019 | 3.13 Mn |
| Sep 30, 2019 | 2.50 Mn |
| Jun 30, 2019 | 5.00 Mn |
| Mar 31, 2019 | 58,000.00 |